A Single Center Trial of Donor Site Wound Dressings After Split Thickness Skin Grafting.

NCT ID: NCT06044519

Last Updated: 2023-09-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-08-01

Study Completion Date

2023-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial\] is to compare different types of dressings used and there outcomes on STSG donor site wound. The main question\[s\] it aims to answer are:

* the effectiveness of different donor site dressings and their adverse outcomes
* the satisfaction of patients with the donor site dressing will be observed. Participants will randomly allocated different types of dressings for split thickness skin graft donor site wound which include alginate hydrocolloid hydrofiber silicon film guaze

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Donor Site Complication Skin Graft Scar

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

alginate

Group Type EXPERIMENTAL

different types of dressings

Intervention Type BIOLOGICAL

different types of dressings were compared ti see the effectiveness for for STSG donor site wound

film

Group Type EXPERIMENTAL

different types of dressings

Intervention Type BIOLOGICAL

different types of dressings were compared ti see the effectiveness for for STSG donor site wound

guaze

Group Type EXPERIMENTAL

different types of dressings

Intervention Type BIOLOGICAL

different types of dressings were compared ti see the effectiveness for for STSG donor site wound

hydrocolloid

Group Type EXPERIMENTAL

different types of dressings

Intervention Type BIOLOGICAL

different types of dressings were compared ti see the effectiveness for for STSG donor site wound

hydrofiber

Group Type EXPERIMENTAL

different types of dressings

Intervention Type BIOLOGICAL

different types of dressings were compared ti see the effectiveness for for STSG donor site wound

silicon

Group Type EXPERIMENTAL

different types of dressings

Intervention Type BIOLOGICAL

different types of dressings were compared ti see the effectiveness for for STSG donor site wound

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

different types of dressings

different types of dressings were compared ti see the effectiveness for for STSG donor site wound

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* . Patients of aged 18 years and above of either gender underwent single donor-site wounds after split-skin grafting and surface area larger than 10 cm2 were included in the study

Exclusion Criteria

* Patients on chemotherapy or corticosteroids were excluded from the study. Non-probability consecutive sampling was employed
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dow University of Health Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dr Ruth KM Pfau civil hospital karachi

Karachi, Sindh, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Approval/2022/943

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

New Treatment for Donor Sites
NCT00591916 WITHDRAWN PHASE2/PHASE3